425
Participants
Start Date
January 25, 2017
Primary Completion Date
May 30, 2018
Study Completion Date
May 30, 2018
Placebo
Placebo is a white powder to be administered using ELLIPTA DPI which hold two individual blister strips, both of which contains lactose monohydrate blended with magnesium stearate.
UMEC
UMEC is a white powder to be administered using ELLIPTA DPI which hold two individual blister strips, one of which contains GSK573719 blended with lactose blended with magnesium stearate and another one contains lactose monohydrate blended with magnesium stearate.
Fluticasone Furoate
FF is a white powder to be administered using ELLIPTA DPI which hold two individual blister strips, one of which contains GW685698 blended with lactose monohydrate and another one contains lactose monohydrate with magnesium stearate.
Albuterol/salbutamol
Albuterol/salbutamol is to be administered via metered-dose inhaler as a rescue drug on need basis throughout the study.
GSK Investigational Site, Raleigh
GSK Investigational Site, Monroe
GSK Investigational Site, Shelby
GSK Investigational Site, Orangeburg
GSK Investigational Site, Spartanburg
GSK Investigational Site, Union
GSK Investigational Site, Old Point Station
GSK Investigational Site, Cincinnati
GSK Investigational Site, Cincinnati
GSK Investigational Site, Minneapolis
GSK Investigational Site, Topeka
GSK Investigational Site, Sunset
GSK Investigational Site, Natchitoches
GSK Investigational Site, Dallas
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Tempe
GSK Investigational Site, Rolling Hills Estates
GSK Investigational Site, Medford
GSK Investigational Site, Piteşti
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Odintsovo
GSK Investigational Site, Yaroslavl
GSK Investigational Site, Arkhangelsk
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, St'Petersburg
GSK Investigational Site, Smolensk
GSK Investigational Site, Râmnicu Vâlcea
GSK Investigational Site, Timișoara
GSK Investigational Site, Deva
GSK Investigational Site, Volgodonsk
GSK Investigational Site, Pyatigorsk
GSK Investigational Site, Voronezh
GSK Investigational Site, Cluj-Napoca
GSK Investigational Site, Samara
GSK Investigational Site, Brasov
GSK Investigational Site, Codlea
GSK Investigational Site, Sibiu
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Barnaul
GSK Investigational Site, Iași
GSK Investigational Site, North Dartmouth
GSK Investigational Site, Calgary
GSK Investigational Site, Vancouver
GSK Investigational Site, Brampton
GSK Investigational Site, Burlington
GSK Investigational Site, Corunna
GSK Investigational Site, Mississauga
GSK Investigational Site, Toronto
GSK Investigational Site, Windsor
GSK Investigational Site, Montreal
GSK Investigational Site, Québec
GSK Investigational Site, Bialystok
GSK Investigational Site, Elblag
GSK Investigational Site, Kielce
GSK Investigational Site, Krakow
GSK Investigational Site, Krakow
GSK Investigational Site, Lodz
GSK Investigational Site, Lublin
GSK Investigational Site, Poznan
GSK Investigational Site, Rzeszów
GSK Investigational Site, Sopot
GSK Investigational Site, Tarnów
GSK Investigational Site, Warsaw
GSK Investigational Site, Wroclaw
GSK Investigational Site, Zgierz
GSK Investigational Site, Bucharest
GSK Investigational Site, Tomsk
Lead Sponsor
GlaxoSmithKline
INDUSTRY